scholarly article | Q13442814 |
P50 | author | Michael H Criqui | Q87223816 |
James S. Pankow | Q30348349 | ||
Michael Y. Tsai | Q37369579 | ||
Matthew A. Allison | Q37385698 | ||
P2093 | author name string | Cecilia Berardi | |
Christina L Wassel | |||
Naomi Q Hanson | |||
Nicholas B Larson | |||
Paul A Decker | |||
Suzette J Bielinski | |||
P2860 | cites work | Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases | Q45052095 |
Aspirin and secondary prevention in peripheral artery disease: a perspective for the early 21st century. | Q46015002 | ||
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers | Q46498134 | ||
Mortality over a period of 10 years in patients with peripheral arterial disease | Q46786119 | ||
Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study | Q47200168 | ||
Soluble P selectin in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease and its risk factors. | Q50973570 | ||
Raised Plasma Soluble P-Selectin in Peripheral Arterial Occlusive Disease Enhances Leukocyte Adhesion | Q57132492 | ||
Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study | Q73407808 | ||
Increased soluble P-selectin in peripheral artery disease: a new marker for the progression of atherosclerosis | Q77737179 | ||
Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management | Q81160258 | ||
Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease | Q84198879 | ||
Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab--preclinical and clinical studies | Q86476800 | ||
A new equation to estimate glomerular filtration rate | Q24651973 | ||
Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease | Q28195300 | ||
Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease | Q28211586 | ||
Multi-Ethnic Study of Atherosclerosis: objectives and design | Q29615490 | ||
Differences in responses of platelets to fluid shear stress in patients with peripheral artery disease (PAD) and coronary artery disease (CAD). | Q33848072 | ||
Baseline lower extremity strength and subsequent decline in functional performance at 6-year follow-up in persons with lower extremity peripheral arterial disease | Q33904160 | ||
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis | Q34100632 | ||
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis | Q34361910 | ||
Cellular adhesion molecules and cardiovascular disease. Part I. Their expression and role in atherogenesis | Q35190631 | ||
Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). | Q35549044 | ||
Adhesion molecules and atherosclerosis | Q35581561 | ||
Leukocyte adhesion and thrombosis | Q36327710 | ||
Functional decline in lower-extremity peripheral arterial disease: associations with comorbidity, gender, and race | Q36352615 | ||
The ARIC carotid MRI study of blood cellular markers: an inverse association of monocyte myeloperoxidase content with peripheral arterial disease | Q36388947 | ||
Peripheral arterial disease: morbidity and mortality implications | Q36565550 | ||
Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study | Q37212527 | ||
Asymptomatic peripheral arterial disease is associated with more adverse lower extremity characteristics than intermittent claudication | Q37361885 | ||
P433 | issue | 2 | |
P921 | main subject | peripheral artery disease | Q378681 |
atherosclerosis | Q12252367 | ||
multiethnicity | Q111242702 | ||
P304 | page(s) | 405-411 | |
P577 | publication date | 2015-01-28 | |
P1433 | published in | Atherosclerosis | Q4813570 |
P1476 | title | Soluble P-selectin predicts lower extremity peripheral artery disease incidence and change in the ankle brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA). | |
P478 | volume | 239 |
Q40304917 | ABO blood group is associated with peripheral arterial disease in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA). |
Q40284152 | Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi-Ethnic Study of Atherosclerosis |
Q30240841 | Biomarkers and Genetics in Peripheral Artery Disease |
Q90327485 | Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors |
Q49733566 | Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent |
Search more.